I have spent a long career in cell and molecular toxicology, directing laboratories in the PreClinical Development Departments of several global Pharmaceutical Companies. I have championed the use of toxicogenomics in drug safety profiling and implemented cell and molecular biology approaches in investigative studies on a variety of drug toxicities. My main interests lie in establishing innovative methods in drug/chemical safety evaluation particularly aimed at early (Discovery Toxicology) safety profiling. I am passionate about applying new thinking along with applying new technologies.